In this review, we will briefly introduce the expression of paxillin in human cancer, its prognostic value, and how it affects malignant tumor progression and molecular mechanism, as well as the evidence contributing towards its potential to be used as a therapeutic target. This evidence concerns the gene PXN and neoplasm.